Literature DB >> 16051895

Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event.

Bruce Ovbiagele1, Nancy K Hills, Jeffrey L Saver, S Claiborne Johnston.   

Abstract

BACKGROUND AND
PURPOSE: Hypertension is poorly controlled in stroke survivors, thereby placing them at increased risk for recurrent events. Clinical trial evidence suggests that antihypertensive treatment may be beneficial for stroke prevention in hypertensive and normotensive stroke patients. We aimed to evaluate the discharge antihypertensive prescription patterns in patients hospitalized for an ischemic cerebrovascular event and to determine factors associated with treatment utilization.
METHODS: We analyzed patients diagnosed with ischemic stroke or transient ischemic attack (TIA) in the California Acute Stroke Prototype Registry (CASPR). We used generalized estimating equations to identify factors independently associated with receiving antihypertensives at the time of hospital discharge.
RESULTS: Data were collected on 764 consecutive patients with ischemic stroke or TIA encountered at 11 hospitals representative of facilities in the state of California. Overall, the rate of discharge with a prescription for any antihypertensive in the CASPR cohort was 69.4%. Hospital-specific rates were heterogeneous (P=0.04), varying from 55% to 100%. In multivariate analysis, independent predictors of prescription for antihypertensive medication at discharge were a history of hypertension (P<0.0001), diabetes (P=0.0009), and older age.
CONCLUSIONS: About two-thirds of patients hospitalized with acute ischemic cerebrovascular events are discharged from the hospital on > or =1 antihypertensive medication. However, there is great variability in prescription rates between hospitals and considerable room for improvement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051895     DOI: 10.1161/01.STR.0000177522.80092.b7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

Review 1.  Lowering of blood pressure for recurrent stroke prevention.

Authors:  Andrea D Boan; Daniel T Lackland; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-07-01       Impact factor: 7.914

Review 2.  Intracerebral hemorrhage specific intensity of care quality metrics.

Authors:  Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

3.  Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort.

Authors:  Christianne L Roumie; Susan Ofner; Joseph S Ross; Greg Arling; Linda S Williams; Diana L Ordin; Dawn M Bravata
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-21

4.  Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.

Authors:  Gulcin Benbir; Birsen Ince; Emre Kumral; Zeki Ongen; Hakan Kultursay; Lale Tokgozoglu; Ali Oto; Hasan Tuzun
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Stroke Prevention: The Best Outcome after a Transient Ischemic Attack. Results from the Minnesota Stroke Registry and Opportunities to Improve Care.

Authors:  Silvina B Tonarelli; Gabriela Vazquez; James M Peacock; Russell V Luepker; Albert W Tsai; Haralabos Zacharatos; Kamakshi Lakshminarayan
Journal:  J Vasc Interv Neurol       Date:  2008-01-01

Review 6.  Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.

Authors:  Stephan Lüders
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Attitudes and practices of resident physicians regarding hypertension in the inpatient setting.

Authors:  Robert Neal Axon; Robin Garrell; Kyle Pfahl; Julie E Fisher; Yumin Zhao; Brent Egan; Alan Weder
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09       Impact factor: 3.738

Review 8.  How well do we care for patients with hypertension?

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-11       Impact factor: 3.738

9.  Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study.

Authors:  Sheena E Ramsay; Peter H Whincup; S G Wannamethee; Olia Papacosta; Lucy Lennon; Mary C Thomas; Richard W Morris
Journal:  J Public Health (Oxf)       Date:  2007-06-21       Impact factor: 2.341

10.  TOAST subtypes: its influence upon doctors' decisions of antihypertensive prescription at discharge for ischemic stroke patients.

Authors:  Jie Xu; Liping Liu; Yilong Wang; Xingquan Zhao; Chunxue Wang; Anxin Wang; Yongjun Wang
Journal:  Patient Prefer Adherence       Date:  2012-12-17       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.